These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21036803)

  • 21. Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stenting.
    Harnek J; Zoucas E; Stenram U; Cwikiel W
    Cardiovasc Intervent Radiol; 2002; 25(5):430-6. PubMed ID: 12042993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intimal hyperplasia by optical coherence tomography after BMS and DES implantation in the same artery.
    Karantalis V; Davlouros P; Alexopoulos D
    Int J Cardiol; 2011 May; 148(3):e66-7. PubMed ID: 19329194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
    Finn AV; Nakazawa G; Kolodgie FD; Virmani R
    JACC Cardiovasc Interv; 2009 Apr; 2(4):300-2. PubMed ID: 19463440
    [No Abstract]   [Full Text] [Related]  

  • 25. [Optical coherence tomography for evaluation of neointimal proliferation after placement of a new drug eluting stent].
    Liu CF; Chen YD; Chen L; Sun ZJ; Gai LY; Liu HB; Tian F; Bai QC; Guo K
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1063-5. PubMed ID: 20501394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe intimal hyperplasia after sirolimus eluting stent deployment: evaluation by optical coherence tomography.
    Gupta R; Raffel OC; Jang IK
    Heart; 2007 Jun; 93(6):754. PubMed ID: 17502657
    [No Abstract]   [Full Text] [Related]  

  • 27. Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS Coronary Radiation to Inhibit Proliferation Post Stenting trial.
    Massullo V; Teirstein PS; Jani S; Russo RJ; Guarneri EM; Jin H; Schatz RA; Morris NB; Steuterman S; Popma JJ; Mintz GS; Leon MB; Tripuraneni P
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):973-5. PubMed ID: 8960532
    [No Abstract]   [Full Text] [Related]  

  • 28. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model.
    De Scheerder I ; Wang K; Zhou XR; Verbeken E; Ping QB; Yanming H; Jianhua H; Szilard M; Van de Werf F
    J Invasive Cardiol; 1999 Jan; 11(1):9-12. PubMed ID: 10745430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restenosis after coronary angioplasty.
    Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME
    Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On OCT and finding the uncovered tracks..
    Ali ZA; Kini A; Sharma SK
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):83-6. PubMed ID: 22239897
    [No Abstract]   [Full Text] [Related]  

  • 32. Very late stent thrombosis after drug-eluting stent in segment with neointimal tissue coverage.
    Nishiguchi T; Kitabata H; Tanaka A; Kataiwa H; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takarada S; Kubo T; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):445-6. PubMed ID: 20394907
    [No Abstract]   [Full Text] [Related]  

  • 33. OCT Visualization of the Structure of Intimal Tissue After Drug-Eluting Balloon Deployment.
    Sakamoto T; Itoh T; Shimoda Y; Fusazaki T; Morino Y
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):983-4. PubMed ID: 25459307
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug-eluting balloon in the treatment of a recurrent in-stent restenosis of drug-eluting stent].
    Merkely B; Jambrik Z
    Orv Hetil; 2010 Sep; 151(37):1509-14. PubMed ID: 20807698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
    Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
    EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The union of anti-CD34 antibody can improve the performance of drug-eluting stents.
    Yang XS; Zhu HG; Yu ZJ; Ren F; Chen YQ; Wu X; Zhang ZC; Zhang LJ; Lu SZ
    Catheter Cardiovasc Interv; 2012 May; 79(6):972-8. PubMed ID: 22162277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventing effect of angiotensin II receptor blocker on neointimal hyperplasia after vascular injury].
    Miyata M; Eto H; Biro S; Tei C
    Nihon Rinsho; 2002 Oct; 60(10):1957-61. PubMed ID: 12397691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.